Skip to main content

Table 7 Adverse Events with Incidence ≧ 2%

From: Effects of paliperidone extended release on the symptoms and functioning of schizophrenia

Preferred Term

N = 426

N (%)

Patients with any Adverse Event

213 (50.0%)

Disease progression

33 (7.7%)*

Upper respiratory tract infection

30 (7.0%)

Extrapyramidal disorder

22 (5.2%)

Insomnia

17 (4.0%)

Constipation

14 (3.3%)

Anxiety

11 (2.6%)

Nasopharyngitis

11 (2.6%)

Diarrhoea

9 (2.1%)

Headache

9 (2.1%)

Somnolence

9 (2.1%)

Tachycardia

9 (2.1%)

  1. *27 events were recorded as serious adverse events.